HomeInsightsStock Comparison

Aurobindo Pharma Ltd vs Innova Captab Ltd Stock Comparison

Aurobindo Pharma Ltd vs Innova Captab Ltd Stock Comparison

Last Updated on: Jun 30, 2025

Key Highlights

  • The Latest Trading Price of Aurobindo Pharma Ltd is ₹ 1146 as of 30 Jun 09:52.
  • The P/E Ratio of Aurobindo Pharma Ltd changed from 8.5 on March 2020 to 20.1 on March 2024 . This represents a CAGR of 18.78% over 5 yearsThe P/E Ratio of Innova Captab Ltd changed from 27.2 on March 2024 to 27.2 on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The Market Cap of Aurobindo Pharma Ltd changed from ₹ 24202 crore on March 2020 to ₹ 63835 crore on March 2024 . This represents a CAGR of 21.41% over 5 yearsThe Market Cap of Innova Captab Ltd changed from ₹ 2564 crore on March 2024 to ₹ 2564 crore on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The revenue of Aurobindo Pharma Ltd for the Mar '25 is ₹ 8516 crore as compare to the Dec '24 revenue of ₹ 8137 crore. This represent the growth of 4.66% The revenue of Innova Captab Ltd for the Mar '25 is ₹ 318.12 crore as compare to the Dec '24 revenue of ₹ 320.79 crore. This represent the decline of -0.83%.
  • The ebitda of Aurobindo Pharma Ltd for the Mar '25 is ₹ 1894 crore as compare to the Dec '24 ebitda of ₹ 1736 crore. This represent the growth of 9.08% The ebitda of Innova Captab Ltd for the Mar '25 is ₹ 51.07 crore as compare to the Dec '24 ebitda of ₹ 50.89 crore. This represent the growth of 0.35%.
  • The net profit of Aurobindo Pharma Ltd changed from ₹ 569.71 crore to ₹ 902.83 crore over 8 quarters. This represents a CAGR of 25.89% The net profit of Innova Captab Ltd changed from ₹ 17.59 crore to ₹ 29.57 crore over 8 quarters. This represents a CAGR of 29.66% .
  • The Dividend Payout of Aurobindo Pharma Ltd changed from 9.37 % on March 2020 to 13.49 % on March 2024 . This represents a CAGR of 7.56% over 5 yearsThe Dividend Payout of Innova Captab Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Aurobindo Pharma Ltd

  • Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company.
  • Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it.
  • APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulations.
  • The company's robust product portfolio is spread over 6 major product areas encompassing (Antibiotics, Anti-Retro Virals, CVS, CNS, Gastroenterologicals, and Anti-Allergics) with around 65 APIs in the non-antibiotics and over 55 APIs in the antibiotic segment and the World Health Organization (WHO), Geneva, has also approved Aurobindo's products.
  • APL is running with 24 manufacturing plants across the world conforming to GMP/ISO regulations and an extremely well equipped 9 R&D facilities.

About Innova Captab Ltd

  • Innova Captab Limited was incorporated as Harun Health Care Private Limited', dated January 3, 2005, as a Private Limited Company at Mumbai.
  • Thereafter, the name of the Company was changed from Harun Health Care Private Limited' to Innova Captab Private Limited', and a fresh Certificate of Incorporation dated February 2, 2010, was issued by RoC to the Company.
  • Subsequently, Company got converted to a Public Company on July 12, 2018, and the name was changed to Innova Captab Limited', dated July 26, 2018. The Company is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports.
  • Their business includes contract development and manufacturing organization (CDMO) business providing manufacturing services to Indian pharmaceutical companies, domestic branded generics business and an international branded generics business.

Aurobindo Pharma Ltd News Hub

News

Lyfius Pharma re-starts production at its Penicillin-G manufacturing facility

Aurobindo Pharma announced that its wholly owned step-down subsidiary, Lyfius Pharma has r...

Read more

30 Jun 2025 09:29

News

Aurobindo Pharma Ltd spurts 0.22%, up for fifth straight session

Aurobindo Pharma Ltd is up for a fifth straight session today. The stock is quoting at Rs ...

Read more

26 Jun 2025 13:00

News

Aurobindo Pharma gets UK MHRA approval for neutropenia treatment drug Dyrupeg

Dyrupeg contains the active substance pegfilgrastim and is a biological medicine. It is a ...

Read more

25 Jun 2025 12:51

News

CuraTeQ Biologics receives UK MHRA approval for biosimilar Dyrupeg'

Aurobindo Pharma announced that CuraTeQ Biologics s.r.o., a wholly owned step-down subsidi...

Read more

24 Jun 2025 19:01

News

Aurobindo Pharma Ltd down for fifth straight session

Aurobindo Pharma Ltd is down for a fifth straight session today. The stock is quoting at R...

Read more

17 Jun 2025 13:35

News

Aurobindo Pharma's US arm incorporates Cresedemo Pharma

The purpose of incorporating this new entity is to expand the company's pharmaceutical pro...

Read more

16 Jun 2025 08:40

Innova Captab Ltd News Hub

News

Innova Captab announces board meeting date

Innova Captab will hold a meeting of the Board of Directors of the Company on 19 May 2025....

Read more

13 May 2025 15:59

News

Innova Captab to table results

Innova Captab will hold a meeting of the Board of Directors of the Company on 5 February 2...

Read more

30 Jan 2025 11:36

News

Innova Captab starts commercial production in Jammu facility

The said facility comprises four dedicated manufacturing blocks, including general, cephal...

Read more

15 Jan 2025 12:23

News

Innova Captab commences commercial production at its facility in Jammu

Innova Captab has commenced commercial production at its state-of-the-art manufacturing fa...

Read more

14 Jan 2025 19:43

News

Innova Captab to announce Quarterly Result

Innova Captab will hold a meeting of the Board of Directors of the Company on 7 November 2...

Read more

30 Oct 2024 17:25

News

Innova Captab to hold AGM

Innova Captab announced that the 20th Annual General Meeting (AGM) of the company will be ...

Read more

26 Aug 2024 14:52

SWOT Analysis Of Innova Captab Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Aurobindo Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Innova Captab Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Aurobindo Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Aurobindo Pharma Ltd and Innova Captab Ltd

Which company has a larger market capitalization, Aurobindo Pharma Ltd or Innova Captab Ltd?

Market cap of Aurobindo Pharma Ltd is 65,795 Cr while Market cap of Innova Captab Ltd is 4,929 Cr

What are the key factors driving the stock performance of Aurobindo Pharma Ltd and Innova Captab Ltd?

The stock performance of Aurobindo Pharma Ltd and Innova Captab Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aurobindo Pharma Ltd and Innova Captab Ltd?

As of June 30, 2025, the Aurobindo Pharma Ltd stock price is INR ₹1122.9. On the other hand, Innova Captab Ltd stock price is INR ₹861.35.

How do dividend payouts of Aurobindo Pharma Ltd and Innova Captab Ltd compare?

To compare the dividend payouts of Aurobindo Pharma Ltd and Innova Captab Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions